CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $2.55B, above the global median of $1.18B
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.55BUSDvs all stocks (USD)
Revenue (TTM)
251.17MUSDvs all stocks (USD)
Profit Margin
-13.36%vs Medical Devices peers
Beta
1.16xvs all stocks
52-Week Change
151.39%vs all stocks
Market Capitalization
2.55BUSDvs all stocks (USD)
Enterprise Value
2.24BUSDvs all stocks (USD)
Forward P/E
63.11xvs Medical Devices peers
Price to Sales (TTM)
10.14xvs Medical Devices peers
Price to Book (MRQ)
9.09xvs Medical Devices peers
Enterprise to Revenue
8.92xvs Medical Devices peers
Gross Margin
72.67%vs Medical Devices peers
Profit Margin
-13.36%vs Medical Devices peers
Operating Margin
-3.09%vs Medical Devices peers
Return on Assets (TTM)
-3.15%vs Medical Devices peers
Return on Equity (TTM)
-18.21%vs Medical Devices peers
Revenue (TTM)
251.17MUSDvs all stocks (USD)
Revenue per Share (TTM)
5.07USDUpdated Sep 26, 2026Quarterly Revenue Growth
23.10%vs Medical Devices peers
Gross Profit (TTM)
187.26MUSDvs all stocks (USD)
EBITDA (TTM)
826.00KUSDvs all stocks (USD)
Net Income (TTM)
-33.55MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
23.06%vs Medical Devices peers
Operating Cash Flow (TTM)
15.05MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
18.23MUSDvs all stocks (USD)
Payout Ratio
0.00%vs Medical Devices peers
Revenue
225.21MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
57.85MUSDFY2025 · Dec 31, 2025Gross Profit
167.35MUSDFY2025 · Dec 31, 2025Operating Income
-7.85MUSDvs all stocks (USD)
Pre-tax Income
-15.70MUSDFY2025 · Dec 31, 2025Net Income
-15.70MUSDFY2025 · Dec 31, 2025EBIT
-8.00MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
826.00KUSDFY2025 · Dec 31, 2025Research & Development
32.88MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
142.32MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
7.70MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.3400USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.3400USDFY2025 · Dec 31, 2025Basic Shares Outstanding
46.05MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
46.05MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-15.70MUSDFY2025 · Dec 31, 2025Operating Cash Flow
10.26MUSDFY2025 · Dec 31, 2025Free Cash Flow
6.52MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
39.55MUSDFY2025 · Dec 31, 2025Interest Paid
6.81MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-15.70MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
8.51MUSDFY2025 · Dec 31, 2025Stock-based Compensation
30.11MUSDFY2025 · Dec 31, 2025Other Non-cash Items
891.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-2.46MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-11.08MUSDFY2025 · Dec 31, 2025Capital Expenditures
-3.75MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-1.85MUSDFY2025 · Dec 31, 2025Purchase of Investments
-13.72MUSDFY2025 · Dec 31, 2025Sale of Investments
14.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-3.47MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-32.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-32.00KUSDFY2025 · Dec 31, 2025Shares Outstanding
53.18MSharesUpdated Sep 26, 2026Float Shares
52.72MSharesUpdated Sep 26, 2026Shares Short
4.06MSharesUpdated Sep 26, 2026Short Ratio
3.46daysvs all stocks
Short % of Shares Outstanding
7.89%vs all stocks
% Held by Insiders
1.98%vs all stocks
% Held by Institutions
90.93%vs all stocks
Total Cash (MRQ)
111.41MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.07USDUpdated Sep 26, 2026Total Debt (MRQ)
20.07MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0783xvs Medical Devices peers
Current Ratio (MRQ)
6.60xvs Medical Devices peers
Book Value per Share (MRQ)
4.78USDUpdated Sep 26, 2026Total Assets
221.69MUSDvs all stocks (USD)
Total Current Assets
120.42MUSDFY2025 · Dec 31, 2025Total Liabilities
92.84MUSDFY2025 · Dec 31, 2025Total Non-current Assets
101.27MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
69.28MUSDFY2025 · Dec 31, 2025Total Current Liabilities
23.56MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
35.55MUSDFY2025 · Dec 31, 2025Other Short-term Investments
5.98MUSDFY2025 · Dec 31, 2025Accounts Receivable
26.17MUSDFY2025 · Dec 31, 2025Inventory
42.37MUSDFY2025 · Dec 31, 2025Accounts Payable
2.89MUSDFY2025 · Dec 31, 2025Short-term Debt
2.37MUSDFY2025 · Dec 31, 2025Long-term Debt
65.26MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
141.00KUSDFY2025 · Dec 31, 2025Common Stock (Book)
472.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-306.96MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
128.85MUSDvs all stocks (USD)
52-Week Low
15.27USDUpdated Sep 26, 202652-Week High
52.91USDUpdated Sep 26, 202652-Week Change
151.39%vs all stocks
Beta
1.16xvs all stocks
50-Day MA
45.64USDUpdated Sep 26, 2026200-Day MA
38.67USDUpdated Sep 26, 2026Avg 10-Day Volume
1.22MSharesUpdated Sep 26, 2026Avg 30-Day Volume
1.15MSharesUpdated Sep 26, 2026Diluted EPS (TTM)
-0.6700USDUpdated Sep 26, 2026Other Income / Expense
-152.00KUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Depreciation-Heavy Reported Profit
It reports a profit, and much of the gap to cash is depreciation rather than earnings.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.73Profit Margin: -0.13
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $2.55B, above the global median of $1.18BNotable
Market cap (USD): 2,545,756,949Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Heron Neutron Medical Corp.
Tier 1ProductionApproval-Gated PipelineRule
Guangzhou Innogen Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Joincare Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MBX Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sinocelltech Group Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Beam Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Disc Medicine Inc.
Tier 1ProductionApproval-Gated PipelineRule
Butterfly Network Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
China Resources Double Crane Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
GN Store Nord A/S
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Flywire Corporation
1 interpretationDepreciation-Heavy Reported Profit
Blade Air Mobility, Inc.
1 interpretationDepreciation-Heavy Reported Profit
The E.W. Scripps Company
1 interpretationDepreciation-Heavy Reported Profit